Page last updated: 2024-10-25

cimetidine and Hyaline Membrane Disease

cimetidine has been researched along with Hyaline Membrane Disease in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Hyaline Membrane Disease: A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McDonnell, M1
Evans, N1

Other Studies

1 other study available for cimetidine and Hyaline Membrane Disease

ArticleYear
Upper and lower gastrointestinal complications with dexamethasone despite H2 antagonists.
    Journal of paediatrics and child health, 1995, Volume: 31, Issue:2

    Topics: Cimetidine; Dexamethasone; Diseases in Twins; Gastrointestinal Hemorrhage; Humans; Hyaline Membrane

1995